% control response (no oAβ42) | oAβ42 5 μM | oAβ42 + SAR228810 | oAβ42 + gantenerumab | oAβ42 + BAN-2401 | |||
---|---|---|---|---|---|---|---|
50 μg/ml | 150 μg/ml | 50 μg/ml | 150 μg/ml | 50 μg/ml | 150 μg/ml | ||
Neurite network (MAP2) | 49.84 ± 10.29 | 86.17 ± 10.25 | 96.49 ± 0.86 | 70.57 ± 1.66 | 82.27 ± 6.70 | 79.34 ± 0.70 | 86.78 ± 2.75 |
p < 0.0001 | p < 0.0001 | p = 0.0022 | p < 0.0001 | p = 0.0059 | p < 0.0001 | ||
Caspase 3/7 activity | 291.47 ± 48.73 | 190.84 ± 39.15 | 103.42 ± 10.36 | 388.89 ± 150.02 | 360.38 ± 123.53 | 428.48 ± 136.51 | 355.14 ± 124.57 |
p = 0.0001 | p < 0.0001 | NS | NS (p = 0.2562) | NS (p = 0.8675) | NS (p = 0.9995) |